BILI vs TIGO

The Advanced Deterministic Scorecard reveals significant concerns with a weak Piotroski F-Score of 2/9, indicating poor financial health, and the absence of an Altman Z-Score limits distress risk assessment. Despite this, BILI shows strong recent price momentum with a 1Y return of +103.3%, robust revenue surprise trends, and a bullish analyst recommendation, offset by stretched valuation metrics such as a P/E of 128.46 versus a sector average of 19.92. Profitability margins and ROE remain below peer averages, while improving earnings surprises and cash flow trends suggest potential operational turnaround. The stock trades at a large premium to both Graham Number ($5.47) and intrinsic value ($1.82), implying high growth expectations are already priced in.

TIGO exhibits a dichotomy between explosive growth and fragile financial health, evidenced by a stable but mediocre Piotroski F-Score of 4/9. While the stock trades significantly above its defensive Graham Number ($62.74), it remains well below its growth-based intrinsic value ($236.88), suggesting long-term upside if leverage is managed. However, a critical technical trend score of 10/100 and a current price ($83.43) exceeding the analyst target ($75.84) indicate a high probability of a short-term correction. The company's exceptional ROE (37.87%) is offset by a concerning Debt/Equity ratio of 2.62 and a liquidity crunch (Current Ratio 0.88).